Journal article
Antiplatelet drugs
Abstract
Antiplatelet drugs protect against myocardial infarction, stroke, cardiovascular death and other serious vascular events in patients with a history of previous vascular events or known risk factors for cardiovascular disease. Aspirin reduces the risk of serious vascular events in patients at high risk of such an event by about a quarter and is recommended as the first-line antiplatelet drug. Clopidogrel reduces the risk of serious vascular …
Authors
Hankey GJ; Eikelboom JW
Journal
The Medical Journal of Australia, Vol. 178, No. 11, pp. 568–574
Publisher
Wiley
Publication Date
6 2003
DOI
10.5694/j.1326-5377.2003.tb05361.x
ISSN
0025-729X